Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001437749-25-002693
Filing Date
2025-02-04
Accepted
2025-02-04 12:26:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10554
2 EXHIBIT 99.1 ex991.htm EX-99.1 9428
  Complete submission text file 0001437749-25-002693.txt   21572
Mailing Address 2560 EAST CHAPMAN AVENUE #173 ORANGE CA 92869
Business Address
Smith Vincent C (Filed by) CIK: 0001106662 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Subject) CIK: 0001818838 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92270 | Film No.: 25586429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)